Tranexamic acid for sepsis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Jun 2021: Trial registered, NCT04910464
  2. 5 Jun 2021: Trial started, NCT04910464

The trials

NCT04910464: Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis

State
Under way
Phase
Phase 3
People
80 planned
Started
5 Jun 2021
Primary completion
10 Jan 2027
Arms
Tranexamic acid
Results
None posted
  1. 2 Jun 2021: Trial registered
  2. 5 Jun 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Cyclo-f, Cyklokapron, Espercil, Femstrual, Haematrix, Lysteda, Rikavarin, TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION, Transamin, Tranexamic Acid 500 MG, Tranexamic acid tablets.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.